<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="66144">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02244788</url>
  </required_header>
  <id_info>
    <org_study_id>2013-059</org_study_id>
    <nct_id>NCT02244788</nct_id>
  </id_info>
  <brief_title>Humanitarian Use of AVANTA Orthopaedics Proximal Interphalangeal Joint</brief_title>
  <official_title>Humanitarian Use of AVANTA Orthopaedics Proximal Interphalangeal Joint</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital for Special Surgery, New York</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital for Special Surgery, New York</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to allow patients to undergo surgery with the SR™ PIP (Proximal
      Interphalangeal) Implants for finger arthritis. This is NOT a research study, but rather, a
      requirement by the FDA for humanitarian use of device
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this IRB approved study is to allow patients to undergo surgery with the SR™
      PIP (Proximal Interphalangeal) Implants. This is NOT a research study, but rather, a
      requirement by the FDA for humanitarian use of device. Use of the SR™ PIP is approved for
      humanitarian use by the FDA when either the patient is in need of a revision of failed PIP
      prothesis(es) or the patient expects to place his/her hand under loading situation which
      preclude the use of an alternative implant in the painful osteo-arthritic and post traumatic
      arthritic PIP joint.
    </textblock>
  </detailed_description>
  <overall_status>Available</overall_status>
  <phase>N/A</phase>
  <study_type>Expanded Access</study_type>
  <has_expanded_access>No</has_expanded_access>
  <condition>Arthroplasty of the PIP Joint</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SR™ PIP</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient is in need of a revision of failed PIP prosthesis(es)

          -  patient expects to place his/her hands under loading situations which preclude the
             use of an alternative implant in the painful osteo-arthritic and post traumatic
             arthritic PIP joint

        Exclusion Criteria:

          -  patient is not in need of a revision of a failed PIP prothesis(es)

          -  patient is eligible to use an alternative implant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Sophia Paul, BA</last_name>
    <phone>212-774-2440</phone>
    <email>pauls@hss.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital for Special Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Sophia Paul, BA</last_name>
      <phone>212-774-2440</phone>
      <email>pauls@hss.edu</email>
    </contact>
    <investigator>
      <last_name>Edward Athanasian, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michelle Carlson, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Duretti Fufa, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Hotchkiss, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lana Kang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Steve Lee, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrew Weiland, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Scott Wolfe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 29, 2017</lastchanged_date>
  <firstreceived_date>September 16, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
